187 related articles for article (PubMed ID: 32526389)
41. Antibiotic resistance in
Jayasingam SD; Zin T; Ngeow YF
Int J Mycobacteriol; 2017; 6(4):387-390. PubMed ID: 29171453
[TBL] [Abstract][Full Text] [Related]
42. Assessment of clarithromycin susceptibility in strains belonging to the Mycobacterium abscessus group by erm(41) and rrl sequencing.
Bastian S; Veziris N; Roux AL; Brossier F; Gaillard JL; Jarlier V; Cambau E
Antimicrob Agents Chemother; 2011 Feb; 55(2):775-81. PubMed ID: 21135185
[TBL] [Abstract][Full Text] [Related]
43. GenoType NTM-DR Performance Evaluation for Identification of Mycobacterium avium Complex and Mycobacterium abscessus and Determination of Clarithromycin and Amikacin Resistance.
Huh HJ; Kim SY; Shim HJ; Kim DH; Yoo IY; Kang OK; Ki CS; Shin SY; Jhun BW; Shin SJ; Daley CL; Koh WJ; Lee NY
J Clin Microbiol; 2019 Aug; 57(8):. PubMed ID: 31167842
[TBL] [Abstract][Full Text] [Related]
44. Mycobacterium massiliense is differentiated from Mycobacterium abscessus and Mycobacterium bolletii by erythromycin ribosome methyltransferase gene (erm) and clarithromycin susceptibility patterns.
Kim HY; Kim BJ; Kook Y; Yun YJ; Shin JH; Kim BJ; Kook YH
Microbiol Immunol; 2010 Jun; 54(6):347-53. PubMed ID: 20536733
[TBL] [Abstract][Full Text] [Related]
45. Multisite reproducibility of results obtained by the broth microdilution method for susceptibility testing of Mycobacterium abscessus, Mycobacterium chelonae, and Mycobacterium fortuitum.
Woods GL; Bergmann JS; Witebsky FG; Fahle GA; Wanger A; Boulet B; Plaunt M; Brown BA; Wallace RJ
J Clin Microbiol; 1999 Jun; 37(6):1676-82. PubMed ID: 10325306
[TBL] [Abstract][Full Text] [Related]
46. Activities of moxifloxacin in combination with macrolides against clinical isolates of Mycobacterium abscessus and Mycobacterium massiliense.
Choi GE; Min KN; Won CJ; Jeon K; Shin SJ; Koh WJ
Antimicrob Agents Chemother; 2012 Jul; 56(7):3549-55. PubMed ID: 22564831
[TBL] [Abstract][Full Text] [Related]
47. Antibiotic susceptibility of diverse Mycobacterium abscessus complex strains in New South Wales, Australia.
Chua KY; Bustamante A; Jelfs P; Chen SC; Sintchenko V
Pathology; 2015 Dec; 47(7):678-82. PubMed ID: 26517625
[TBL] [Abstract][Full Text] [Related]
48. Efficacies of three drug regimens containing omadacycline to treat Mycobacteroides abscessus disease.
Rimal B; Panthi CM; Xie Y; Belz DC; Ignatius EH; Lippincott CK; Deck DH; Serio AW; Lamichhane G
Tuberculosis (Edinb); 2024 May; 146():102482. PubMed ID: 38364332
[TBL] [Abstract][Full Text] [Related]
49. Evaluation of the new GenoType NTM-DR kit for the molecular detection of antimicrobial resistance in non-tuberculous mycobacteria.
Mougari F; Loiseau J; Veziris N; Bernard C; Bercot B; Sougakoff W; Jarlier V; Raskine L; Cambau E;
J Antimicrob Chemother; 2017 Jun; 72(6):1669-1677. PubMed ID: 28333340
[TBL] [Abstract][Full Text] [Related]
50. A novel DNA chromatography method to discriminate Mycobacterium abscessus subspecies and macrolide susceptibility.
Yoshida M; Sano S; Chien JY; Fukano H; Suzuki M; Asakura T; Morimoto K; Murase Y; Miyamoto S; Kurashima A; Hasegawa N; Hsueh PR; Mitarai S; Ato M; Hoshino Y
EBioMedicine; 2021 Feb; 64():103187. PubMed ID: 33446475
[TBL] [Abstract][Full Text] [Related]
51. Predominance of clarithromycin-susceptible Mycobacterium massiliense subspecies: Characterization of the Mycobacterium abscessus complex at a tertiary acute care hospital.
Chew KL; Cheng JWS; Hudaa Osman N; Lin RTP; Teo JWP
J Med Microbiol; 2017 Oct; 66(10):1443-1447. PubMed ID: 28874233
[TBL] [Abstract][Full Text] [Related]
52. Erm(41)-dependent inducible resistance to azithromycin and clarithromycin in clinical isolates of Mycobacterium abscessus.
Maurer FP; Castelberg C; Quiblier C; Böttger EC; Somoskövi A
J Antimicrob Chemother; 2014 Jun; 69(6):1559-63. PubMed ID: 24500188
[TBL] [Abstract][Full Text] [Related]
53. AR-12 Exhibits Direct and Host-Targeted Antibacterial Activity toward
Zhang S; Zou Y; Guo Q; Chen J; Xu L; Wan X; Zhang Z; Li B; Chu H
Antimicrob Agents Chemother; 2020 Jul; 64(8):. PubMed ID: 32482678
[TBL] [Abstract][Full Text] [Related]
54. Synergistic activities of tigecycline with clarithromycin or amikacin against rapidly growing mycobacteria in Taiwan.
Huang CW; Chen JH; Hu ST; Huang WC; Lee YC; Huang CC; Shen GH
Int J Antimicrob Agents; 2013 Mar; 41(3):218-23. PubMed ID: 23312605
[TBL] [Abstract][Full Text] [Related]
55. Discrepancies between the genotypes and phenotypes of clarithromycin-resistant
Yoshida S; Tsuyuguchi K; Kobayashi T; Tomita M; Inoue Y; Hayashi S; Suzuki K
Int J Tuberc Lung Dis; 2018 Apr; 22(4):413-418. PubMed ID: 29562989
[TBL] [Abstract][Full Text] [Related]
56. A single-gene approach for the subspecies classification of Mycobacteroides abscessus.
Ng HF; Ngeow YF
Pathog Dis; 2020 Nov; 78(8):. PubMed ID: 32945880
[TBL] [Abstract][Full Text] [Related]
57. Clinical outcome of Mycobacterium abscessus infection and antimicrobial susceptibility testing.
Huang YC; Liu MF; Shen GH; Lin CF; Kao CC; Liu PY; Shi ZY
J Microbiol Immunol Infect; 2010 Oct; 43(5):401-6. PubMed ID: 21075707
[TBL] [Abstract][Full Text] [Related]
58. Macrolide treatment for Mycobacterium abscessus and Mycobacterium massiliense infection and inducible resistance.
Choi GE; Shin SJ; Won CJ; Min KN; Oh T; Hahn MY; Lee K; Lee SH; Daley CL; Kim S; Jeong BH; Jeon K; Koh WJ
Am J Respir Crit Care Med; 2012 Nov; 186(9):917-25. PubMed ID: 22878281
[TBL] [Abstract][Full Text] [Related]
59. Investigation of the population structure of Mycobacterium abscessus complex strains using 17-locus variable number tandem repeat typing and the further distinction of Mycobacterium massiliense hsp65 genotypes.
Yoshida S; Arikawa K; Tsuyuguchi K; Kurashima A; Harada T; Nagai H; Suzuki K; Iwamoto T; Hayashi S
J Med Microbiol; 2015 Mar; 64(Pt 3):254-261. PubMed ID: 25596119
[TBL] [Abstract][Full Text] [Related]
60. Clinical significance of differentiation of Mycobacterium massiliense from Mycobacterium abscessus.
Koh WJ; Jeon K; Lee NY; Kim BJ; Kook YH; Lee SH; Park YK; Kim CK; Shin SJ; Huitt GA; Daley CL; Kwon OJ
Am J Respir Crit Care Med; 2011 Feb; 183(3):405-10. PubMed ID: 20833823
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
